'The Global Gastrointestinal Devices Market Will Reach $18.2 Billion in 2015' Predicts Visiongain

LONDON, March 8, 2013 /PRNewswire/ --

A new report by visiongain predicts that the global market for gastrointestinal devices will reach $18.2bn in 2015. That revenue forecast and others appear in Gastrointestinal Devices: World Market 2013-2023, published in March 2013. Visiongain is a business information provider based in London, UK.

Visiongain predicts that the gastrointestinal devices will grow steadily to 2023. The future of the gastrointestinal devices market appears promising. There is significant potential for growth and investment, driven by the increasing demand for safer and cost-effective therapies.

The gastrointestinal devices market is diverse in its technologies and its geographic distribution. It is currently comprised of innovative gastrointestinal devices for the treatment of a wide range of disorders that include oesophageal cancer, stomach cancer, colon cancer, Crohn's disease and many others. Despite the market being dominated by a few large medical device manufacturers, there are several small companies manufacturing niche and innovative products. Each company has employed unique market and positioning strategies in an effort to increase their market share in the global market place. An example of this is the growing research and investment being focused on developing minimally invasive surgical procedures, saving procedure time and reducing hospital stay.

Rodrigo Gutierrez Gamboa, a healthcare industry analyst in visiongain, said: "The gastrointestinal devices market is an attractive and highly profitable market. However, it is also an intensely competitive market place. Competition within this sector of the medical device industry continues to be largely based on clinical results and product design. In addition, price competition is an important factor as healthcare providers have continuing concerns over costs.

"A positive reimbursement outlook for some gastrointestinal device segments will drive growth, particularly in the endoscopy market. Emerging countries such as China and India will see strong growth in their respective gastrointestinal device markets, owing to an increase in healthcare expenditure and insurance coverage as a result of their rapidly expanding economies. As expected, most of the leading companies reported double-digit sales growth in the emerging markets during the 2011 fiscal period.

"Companies that wish to remain competitive in this market need to heavily invest in their research and development capabilities. Through this they can achieve a competitive advantage over rivals, promoting clear product differentiation. Our research suggests that new products and line extensions of existing products represent a significant component of future growth rate in the gastrointestinal devices market".

Visiongain's report gives revenue forecasts to 2023 at overall world market, service submarket and national level. It forecasts world sales for the following segments:
• Gastrointestinal endoscopy
• Ostomy devices
• Bariatric surgery devices
• Enteral feeding pumps.

That investigation includes analyses of seven leading companies, including Ethicon-Endo Surgery (J&J), Olympus, Boston Scientific, Coloplast, Given Imaging, CONMED and Covidien.

The study includes researching trends and forecasting revenues in leading national markets. Countries analysed are the US, Japan, Germany, France, the UK, Spain, Italy, India and China. The analysis also discusses opportunities and developments - technological and commercial.
Gastrointestinal Devices: World Market 2013-2023 adds to visiongain's range of analytical reports on industries and markets in healthcare, including those on pharmaceutical outsourcing.
For sample pages and further information concerning the visiongain Gastrointestinal Devices: World Market 2013-2023 report please visit: http://www.visiongain.com/Report/996/Gastrointestinal-Devices-World-Market-2013-2023

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44-(0)-207-336-6100

Companies Listed

Abbott
Aesculap
ALCOR Scientific
Allergan
American HomePatient
Arena Pharmaceuticals
Attends Healthcare Products
Bariatric Solutions
Boston Scientific
Braun Melsungen
C.R. Bard
Cardinal Health
Central Drug Standard Control Organisation (CDSCO)
Coloplast
CONMED
ConvaTec
Cook Medical
Cousin Biotech
Covidien
Danone
EnteroMedics
European Medicines Agency (EMA)
ev3
First Quality Enterprises
Fresenius Kabi
Fujifilm
Fujinon Endoscopy
GI Dynamics
Given Imaging
Global Harmonisation Task Force (GHTF)
Gyrus ACMI
Helioscopie
Hollister
Italian National Health Service
Japanese Ministry of Health, Labour and Welfare (MHLW)
Johnson and Johnson (J&J)
Kao Corporation
Karl Storz
Kimberly-Clark Corporation
Lumenis
Medical Device Regulators Forum (IMDRF)
Medical Innovation Development Company
Ministry of Health of the People's Republic of China
Moog Inc.
National Institute for Health and Clinical Excellence (NICE)
Nestle
Nutricia Advanced Medical Nutrition
Olympus
ONTEX International
Orexigen Therapeutics
OST Medical
PARE Surgical
Patient Centered Outcomes Research Institute (PCORI)
Paul Hartmann
Pentax Medical
Pigeon Corporation
Q Core Medical
Richard Wolf
Salts Healthcare
Satiety Inc.
Spirus Medical
SterilMed
Stryker Corporation
Surgical IOC
Svenska Cellulosa Aktiebolaget
Synthes
Uni-Charm Corporation
United Nations (UN)
US Endoscopy
US Food and Drug Administration (FDA)
Vivus
Welch Allyn
World Health Organization (WHO) 

About visiongain

Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Energy, Telecoms, Pharmaceutical, Defence, Materials sectors.

For an executive summary please contact:
Email: Sara Peerun on sara.peerun@visiongainglobal.com
Tel: +44(0)20-7336-6100